Boston Scientific Estimates 2024 Net Sales Growth Of Approximately 13.5%-14.5% On A Reported Basis And 13%-14% On An Organic Basis, Compared To Prior Guidance Of 11%-13% And 10%-12%, Respectively
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has updated its 2024 net sales growth estimates to 13.5%-14.5% on a reported basis and 13%-14% on an organic basis, which is an increase from the prior guidance of 11%-13% and 10%-12%, respectively.
July 24, 2024 | 10:38 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific has increased its 2024 net sales growth estimates, indicating stronger than expected performance. This positive revision is likely to boost investor confidence and drive the stock price up in the short term.
The upward revision in sales growth estimates suggests that Boston Scientific is performing better than previously anticipated. This is a strong positive signal for investors, likely leading to increased demand for the stock and a short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100